BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma

lymphoma, recurrent cutaneous t-cell non-hodgkin lymphoma, stage i cutaneous t-cell non-hodgkin lymphoma, stage ii cutaneous t-cell non-hodgkin lymphoma, stage iii cutaneous t-cell non-hodgkin lymphoma, stage iv cutaneous t-cell non-hodgkin lymphoma, recurrent mycosis fungoides/sezary syndrome, stage i mycosis fungoides/sezary syndrome, stage ii mycosis fungoides/sezary syndrome, stage iii mycosis fungoides/sezary syndrome, stage iv mycosis fungoides/sezary syndrome, interventional